Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Granulocyte Colony-Stimulating Factor (G-CSF) Mobilization”

71 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 71 results

Testing effectiveness (Phase 2)Study completedNCT00025545
What this trial is testing

Filgrastim-Treated Donor Peripheral Stem Cell Transplantation in Treating Patients With Acute Leukemia</p>

Who this might be right for
Leukemia
Fred Hutchinson Cancer Center
Early research (Phase 1)Study completedNCT01074060
What this trial is testing

Plerixafor and Filgrastim Following Cyclophosphamide for Stem Cell Mobilization in Patients With Multiple Myeloma

Who this might be right for
Refractory Multiple MyelomaStage I Multiple MyelomaStage II Multiple Myeloma+1 more
City of Hope Medical Center 18
Not applicableStudy completedNCT01884610
What this trial is testing

Study on the Impact of Stem Cell Donation and Bone Marrow Harvesting on Unrelated Donors

Who this might be right for
Chromosome Aberrations
University College, London 50
Not applicableStudy completedNCT02037256
What this trial is testing

Bortezomib and Filgrastim to Promote Stem Cell Mobilization in Patients With Non-Hodgkin Lymphoma or Multiple Myeloma

Who this might be right for
Adult Grade III Lymphomatoid GranulomatosisB-cell Chronic Lymphocytic LeukemiaContiguous Stage II Adult Burkitt Lymphoma+86 more
Barbara Ann Karmanos Cancer Institute 23
Early research (Phase 1)Study completedNCT00400556
What this trial is testing

ATRA Plus G-CSF for Mobilization of Hematopoietic Stem and Progenitor Cells

Who this might be right for
Multiple MyelomaCutaneous Lymphoma
Peter MacCallum Cancer Centre, Australia 6
Testing effectiveness (Phase 2)Ended earlyNCT01182675
What this trial is testing

Hematopoietic Stem Cell Transplantation (HSCT) for Children With SCID Utilizing Alemtuzumab, Plerixafor & Filgrastim

Who this might be right for
Severe Combined Immunodeficiency
University of California, San Francisco 7
Testing effectiveness (Phase 2)Study completedNCT00499343
What this trial is testing

G-CSF Versus G-CSF Plus GM-CSF for Stem Cell Mobilization in NHL Patients

Who this might be right for
Lymphoma
M.D. Anderson Cancer Center 84
Large-scale testing (Phase 3)Looking for participantsNCT00785525
What this trial is testing

Filgrastim-Mobilized Stem Cells for Transplantation Using Unrelated Donors

Who this might be right for
Healthy
Center for International Blood and Marrow Transplant Research 60,000
Not applicableStudy completedNCT00001071
What this trial is testing

Stem Cells and Filgrastim

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 24
Testing effectiveness (Phase 2)Study completedNCT00004157
What this trial is testing

Interleukin-11 Plus Filgrastim Prior to Peripheral Stem Cell Transplantation in Patients With Non-Hodgkin's Lymphoma, Hodgkin's Disease, Breast Cancer, or Other Solid Tumors

Who this might be right for
Breast CancerGestational Trophoblastic TumorKidney Cancer+5 more
Fred Hutchinson Cancer Center
Testing effectiveness (Phase 2)UnknownNCT00922389
What this trial is testing

A Clinical Trial on Diabetic Foot Using Peripheral Blood Derived Stem Cells for Treating Critical Limb Ischemia

Who this might be right for
Diabetic FootCritical Limb IschemiaLeg Ulcers
Beike Biotech India Pvt.ltd 36
Not applicableEnded earlyNCT01408043
What this trial is testing

Etoposide, Filgrastim, and Plerixafor in Improving Stem Cell Mobilization in Treating Patients With Non-Hodgkin Lymphoma

Who this might be right for
Adult Acute Lymphoblastic Leukemia in RemissionAdult Grade III Lymphomatoid GranulomatosisAdult Nasal Type Extranodal NK/T-cell Lymphoma+31 more
Case Comprehensive Cancer Center 25
Testing effectiveness (Phase 2)Study completedNCT00066092
What this trial is testing

Pegfilgrastim PBPC Mobilization Study

Who this might be right for
LymphomaHodgkin's LymphomaNon-Hodgkin's Lymphoma+2 more
Amgen 41
Testing effectiveness (Phase 2)Study completedNCT02221492
What this trial is testing

Plerixafor Plus Granulocyte Colony-Stimulating Factor For Mobilization And Collection Of Peripheral Hematopoietic Stem Cells In Japanese Participants With Non-Hodgkin Lymphoma

Who this might be right for
Lymphoma
Genzyme, a Sanofi Company 32
Testing effectiveness (Phase 2)Study completedNCT00117455
What this trial is testing

Peripheral Blood Progenitor Cell (PBPC) Mobilisation by Chemotherapy With Pegfilgrastim or Filgrastim in Subjects With Non-Hodgkin's Lymphoma

Who this might be right for
Non-Hodgkin's Lymphoma
Amgen
Testing effectiveness (Phase 2)Study completedNCT00008268
What this trial is testing

Melphalan and Filgrastim to Stimulate Peripheral Stem Cells in Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
Memorial Sloan Kettering Cancer Center
Large-scale testing (Phase 3)Ended earlyNCT03029000
What this trial is testing

Study of the Effect of a 5-Day Regimen of Study Drug on Peripheral Stem Cell Mobilization in Healthy Participants

Who this might be right for
Healthy Participants
Teva Branded Pharmaceutical Products R&D, Inc. 1
Not applicableStudy completedNCT00511550
What this trial is testing

Filgrastim-Mobilized Peripheral Blood Stem Cells for Allogeneic Transplantation With Unrelated Donors

Who this might be right for
Healthy
University of California, San Francisco 15
Testing effectiveness (Phase 2)Study completedNCT00948922
What this trial is testing

Melphalan+Bortezomib as a Conditioning Regimen for Autologous and Allogeneic Stem Cell Transplants in Multiple Myeloma

Who this might be right for
Multiple Myeloma
H. Lee Moffitt Cancer Center and Research Institute 124
Not applicableEnded earlyNCT01899326
What this trial is testing

Desipramine Hydrochloride and Filgrastim For Stem Cell Mobilization in Patients With Multiple Myeloma Undergoing Stem Cell Transplant

Who this might be right for
DS (Durie/Salmon) Stage I Plasma Cell MyelomaDS Stage II Plasma Cell MyelomaDS Stage III Plasma Cell Myeloma+1 more
Albert Einstein College of Medicine 10
Next Page